Organization
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
5 clinical trials
Clinical trial
An Early Phase Randomized Trial of APX005M in BRCAwt Patients With Recurrent Ovarian CancerStatus: Withdrawn, Estimated PCD: 2023-09-07
Clinical trial
NSGO-OV-UMB1; ENGOT-OV30 / NSGO: A Phase II Umbrella Trial in Patients With Relapsed Ovarian CancerStatus: Completed, Estimated PCD: 2021-10-19
Clinical trial
A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients With Recurrent Ovarian CancerStatus: Recruiting, Estimated PCD: 2024-12-15
Clinical trial
ENGOT-EN1/FANDANGO: A Randomized Phase II Trial of First-line Combination Chemotherapy With Nintedanib / Placebo for Patients With Advanced or Recurrent Endometrial CancerStatus: Completed, Estimated PCD: 2021-10-20
Clinical trial
ENGOT-EN3-NSGO/PALEO: A Randomized, Double-blind, Placebo-controlled, Phase II Trial of Palbociclib in Combination With Letrozole Versus Placebo in Combination With Letrozole for Patients With Estrogen Receptor Positive Advanced or Recurrent Endometrial Cancer.Status: Completed, Estimated PCD: 2020-12-15